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ABSTRACT 
Background 
Rapid development in health care has resulted in an increasing number of screening and 
treatment options. Consequently, there is an urgency to provide patients with relevant 
information about benefits and risks of health care options in an unbiased way. Decision 
aids help patients make decisions by providing unbiased non-directive research evidence 
about all treatment options. 
Objective  
To determine the effectiveness of decision aids to improve informed decision making in 
pregnancy care.  
Search strategy 
We searched MEDLINE (1953-2011), EMBASE (1980-2011), CENTRAL (CENTRAL, the 
Cochrane Library; 2011, Issue 4), Psycinfo (1806-2011) and Research Registers of 
ongoing trials (www.clinicaltrials.gov, www.controlled-trials.com). 
Selection criteria 
We included  randomised controlled trials comparing decision aids in addition to standard 
care. The study population needed to be pregnant women making actual decisions 
concerning their pregnancy.  
Data collection and analysis 
Two independent researchers extracted data on quality of the randomised controlled trial 
(GRADE criteria), quality of the decision aid (IPDAS criteria), and outcome measures. 
Data analysis was undertaken by assessing group differences at first follow-up after the 
interventions.  
Main results 
Ten randomised controlled trials could be included. Pooled analyses showed that decision 
aids significantly increased knowledge, (weighted mean difference 11.06, 95% CI: 4.85, 
17.27), decreased decisional conflict scores (weighted mean difference -3.66, 95%CI:-
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6.65, -0.68)) and decreased anxiety (weighted mean difference -1.56, 95%CI:-2.75, -
0.43).  
Conclusions 
Our systematic review showed the positive effect of decision aids on informed decision 
making in pregnancy care. Future studies should focus on increasing the uptake of 
decision aids in clinical practice by identifying barriers and facilitators to implementation.  
Keywords 
Decision aids, informed decision making, pregnancy healthcare, obstetrics, systematic 
review
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INTRODUCTION 
Rapid development in health care technology and interventions has resulted in an 
increasing number of screening and treatment options. Many decisions in health care do 
not have a single best option but rather a number of ‘close call’ decisions that are 
ultimately influenced by patient preference. In pregnancy, for example, patient 
preferences are instrumental in decisions on first trimester screening or analgesia during 
labour. Consequently, there is an urgency to inform patients and provide relevant 
information about both the benefits and risks of health care options in an unbiased way.  
Counselling pregnant women is challenging as these women not only need to consider 
their own health, but also the health of the fetus and consequences for subsequent 
pregnancies, which makes it a complicated decision. Previous studies have highlighted 
that pregnant women want to be involved in decision making.{Waldenstrom, 2006 123 
/id;Brown, 1994 122 /id}  
Decision aids (DA), or decision support techniques, aim to help patients make these close 
call decisions by providing unbiased non-directive research evidence about all treatment 
options, including the risks and benefits, and assisting patients in clarifying their personal 
values related to corresponding outcomes and side effects.3;4 Standard education 
materials, such as leaflets, help patients understand their diagnosis, treatment, and 
management, but differ from DAs as they do not necessarily facilitate informed decision 
making by exploring personal values and preferences.5 DAs are intended to be an adjunct 
to usual care and should not influence intervention uptake.3  
[DELETE?  A large systematic review of over 500 patient DAs by O’Connor and colleagues 
have demonstrated  the overall  effectiveness and additional value of DAs for people 
facing health treatment or screening decisions. . Although a number of DAs related to 
aspects of pregnancy care have been developed and evaluated, there has been no review 
of the overall efficacy of these aids in pregnancy care.{Nassar, 2007 166 /id;Nagle, 2006 
168 /id;Montgomery, 2007 205 /id}]We are specifically interested in the additional value 
 5 
of DAs for pregnant women due to the multiple consequences of their choices, and 
additional impact on their baby and family, as well as their own health. 
 
The aim of this study was to conduct a systematic review of randomised trials to 
summarize the available decision support techniques, and to assess their quality and 
their effectiveness for pregnancy care. 
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METHODS 
Sources 
We searched MEDLINE (1953-2011), EMBASE (1980-2011), CENTRAL (CENTRAL, the 
Cochrane Library; 2011, Issue 4) and Psycinfo (1806-2011) up to March 2011 using 
keywords: choice behaviour, decision making, decision support techniques, decision$, 
(choic$ or preference$), informed consent, pregnancy, labour, birth. No time or language 
restrictions were applied. Reference lists of eligible studies, previously published 
systematic reviews and review articles, as well as the website of the Patient Decision Aids 
research group (www.ohri.ca/decisionaid/) were checked to identify cited trials not 
captured by electronic searches. We searched research registers for ongoing trials 
(www.clinicaltrials.gov, www.controlled-trials.com). 
 
Study Selection 
We included studies using a randomised controlled trial (RCT) or cluster randomised 
design evaluating DAs. Study populations needed to include pregnant women, who were 
facing the relevant pregnancy care decision  in their current pregnancy. DAs were defined 
as interventions which provide unbiased and non-directive information to help pregnant 
women make choices based on personal values. They should contain information on all 
treatment options (including expectant management), and  outcomes relevant to a 
person’s health status. Furthermore, implicit methods to clarify values should also be 
presented. We included RCTs which compared pregnancy care DAs to no intervention, 
usual care, alternative interventions, or a combination. We excluded studies whose 
interventions did not meet the criteria of a DA or where the DA was not available and the 
article did not provide enough information to determine that the intervention met the 
minimum criteria to qualify as a patient DA, according to the International Patient 
Decision Aid Standards (IPDAS) criteria. These criteria assess the quality of DAs and 
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were developed by over 100 experts from various decision making fields and 
representing 14 countries, using the Delphi consensus process.3  
 
Outcome measures 
We studied decisional conflict score (DCS), knowledge and anxiety. Decisional conflict 
refers to uncertainty in chosen option and the score ascertains whether individuals had 
clarity of values and felt informed and supported in decision making. Knowledge is 
assessed using specific questions concerning the topic of the DA and usually consists of 
several true/false or multiple choice questions. Anxiety is often examined in these studies 
to confirm that DAs do not increase anxiety by providing too much detailed information. 
Anxiety was usually measured using the State-Trait Anxiety Scale. Secondary outcomes 
assessed were effectiveness of DA (proportion of individuals undecided, accuracy of risk 
perception of treatment options, enough information to make decision, involvement in 
decision making, regret of choice and satisfaction with choice); acceptability of DA 
(readability of DA, and usefulness of information to make choice); decision behaviour 
outcomes (outcome of decision, uptake of intervention, and adherence to chosen option); 
health outcomes (neonatal and maternal morbidity and mortality, Apgar score, 
gestational age at delivery, and depression and self-esteem); and healthcare-system 
outcomes (cost-effectiveness of the DA, length of stay in hospital and length of 
consultation).  
 
Quality assessment  
Quality of included studies was assessed by examining risk of bias, using the criteria 
outlined in the Cochrane Handbook for Systematic Reviews of Interventions.6 Quality of 
evidence was assessed using the GRADE scale.7 The International Patient Decision Aid 
Standards (IPDAS) Collaboration quality criteria framework was used to assess the 
quality of the DA.8 Final DAs were retrieved from a number of sources including internet 
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articles, theses, or by contacting authors. If unavailable, the quality of the DA was 
assessed using information provided in the articles of the RCT, pilot study or protocol. 
Studies were excluded if the intervention did not qualify as a DA according to the IPDAS 
criteria used for scoring and where adequate information on the contents could not be 
obtained. The maximum IPDAS score ranged from 50 to 64 points, depending on the 
extensiveness of the DA (additional scoring items for patient stories, internet based DAs 
and DAs on screening tests). We converted scores to percentages of total scores. At the 
time of assessment there were no defined scores/categories for good vs. poor quality 
DAs, or guidelines on interpretation of the scores. Therefore, we categorized DAs 
according to two arbitrary points (<60% of total scores) to define low quality.  
 
Data extraction and statistical analysis 
Two review authors (FV and JKW) independently assessed all potential studies for 
inclusion and extracted data. Inconsistencies were resolved by discussion and consensus 
and/or by consulting a third person (NN). Data extracted included information relevant to 
study characteristics, methodological quality (method of randomisation, allocation 
concealment, and degree of blinding); study population and inclusion/ exclusion criteria; 
topic of decision, type of intervention and comparator and respective formats; and 
number of women in each study group and quantitative and/or qualitative data relating 
to the selected primary and secondary outcomes, where available. Where relevant data 
were not reported, we contacted corresponding authors for additional information. 
Studies were categorized according to topic, quality of the DA, format of the DA and type 
of intervention in the control group.  
Data analysis for each primary and secondary outcome was undertaken by assessing 
group differences at first follow-up after the administration of the interventions. We were 
unable to evaluate differences over time (baseline measurements before intervention and 
at first follow up), as most studies did not report standard deviations over time. If 
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different scales to measure the same outcome were used among studies, the scales were 
converted to the scale with the largest range. Continuous measures were assessed by 
comparing the means and standard deviations between the two treatment groups and 
calculating pooled weighted mean differences. For dichotomous data we used relative risk 
to calculate pooled relative risk. We calculated missing values such as standard 
deviations, mean differences, relative risks and 95% confidence intervals where possible 
or wrote to authors for additional information on the outcomes. The I2 test was used to 
assess variability between the studies and where we found strong evidence of 
heterogeneity (I2>50%), we analysed data with a random effects model. Subgroup 
analyses were conducted to take into account potential differences in the type of 
intervention applied in the control group (usual care or information programme), format 
of DAs (booklet, counselling and computer program) and quality of DAs (<60% and 
>60% scores). For analysing decision behaviour and health outcomes we pooled and 
assessed outcomes per topic of the DA. We also examined evidence of publication bias 
using funnel plots and plotting the standard error of the risk difference (or odds ratio) by 
the risk difference (or odds ratio) and of these for skewness6. All analyses were 
conducted using STATA version 9.2, 2007. 
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RESULTS 
Search results 
We critically appraised 6064 unique citations from the databases of which we reviewed 
92 abstracts and selected 26 articles for further reading and assessment. Of these, 10 
articles were identified and included in the systematic review. Reasons for exclusion are 
reported in Figure 1. We identified four possible ongoing trials and approached authors 
for information on the status of the trials; one trial evaluated a health care provider DA, 
one study was still recruiting (April 2011) and no response was received from the other 
two research groups, so these were not included10-13 
 
Characteristics of the ten studies included in this review can be found in Table 1. Scores 
of methodological quality assessment are presented in Table 2; blinding for this type of 
intervention is difficult, but most studies did try to limit contamination and blinded care 
providers by employing a research nurse or research assistant to administer the DA. Most 
studies did not report if there was blind outcome assessment. Loss to follow-up varied 
greatly; Raynes-Greenow, Kupperman, Arimori and Shorten had more than 10% loss of 
respondents at the time of first follow up (comprising of an assessment after the 
intervention).14-17 
 
Type of DA and quality assessment 
The ten decisions investigated in the included studies were: first trimester pregnancy 
termination method18, prenatal testing14;15;19-21, management of breech presentation22, 
mode of delivery after previous caesarean section17;23;24, and labour analgesia16;23;25. We 
identified three formats of DAs: six studies used a booklet as intervention 16;22;26-29 (three 
included an audio-guide), two used an interactive computer program15;24 and two studies 
used structured counselling14;19.  
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Five out of ten studies compared a DA to usual (verbal) counselling. Other studies used 
group counselling, a placebo intervention (information leaflet on relevant topic), or an 
information program as control group. 
We obtained access to five out of ten DAs. 16;21;22;24;29 The other DAs were scored based 
on the information provided in the articles. IPDAS scores ranged from 27.3% (15 out of 
55 points) to 83.0% (44 out of 53 points) (Table 1). The lower scores tended to be those 
where we did not have access to the DA and where there was a lack of information 
regarding the developmental process.14;29   
 
Decisional conflict score 
The overall DCS was the most commonly presented outcome (6 studies).14;21;22;24;28;29 
Articles used different DCS scales, so we converted them to a 0-100 scale for pooled data 
analysis. A lower score is associated with less decisional conflict and a score below 25 is 
generally considered as good decision making.15 There was a significant difference in DCS 
at first follow up with a weighted mean difference (WMD) of -3.66 (95% CI: -6.65, -0.68) 
in favour of DAs (figure 2). Subgroup analysis showed similar results regardless of the 
type (booklet, computer program or counselling) or quality (low (<60) or high (>60) 
IPDAS scores) of the decision support technique (Table 3). However, the type of control 
intervention did make a difference to decisional conflict with a stronger effect evident 
when comparison group was usual care (WMD -5.75, 95%CI -7.75, -3.75), but no 
difference was observed when comparing the DA with other information leaflets16;21. 
 
Knowledge 
Five studies assessed knowledge at both baseline and first follow-up.16;19;22;24;29 We 
carried out a pooled analysis for knowledge scores at first follow-up, calculated as the 
percentage of correctly answered questions. The WMD was 11.06% (95% CI: 4.85, 
17.27) in favour of the DA group (figure 3). There was a similar positive effect of the DA 
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on knowledge regardless of most types of DA, control intervention, or IPDAS quality 
score (Table 3). However, there was little effect and no difference in knowledge scores 
when the DA was in the form of counselling (Table 3). 
 
Anxiety  
Anxiety was assessed by six studies at first follow up.16;19;21;22;24;29 Pooled analysis 
showed significantly lower anxiety in DA versus comparison groups (WMD -1.59 (95% 
CI: -2.75, -0.43)) (figure 4). Similar results were found in all of the subgroup analyses 
with the biggest differences reported when DAs were compared to usual care or when the 
intervention involved some form of counselling or interactive computer program (Table 
3). Smaller benefits were observed when DAs were either in the form of a booklet or 
compared to other information leaflets (Table 3).  
 
Other secondary outcomes 
Various measures were applied to assess the impact of DAs on decision-making. This 
included assessment of decisional regret, enough information to make a decision, and 
increase in understanding of treatment options. The studies assessing these outcomes 
showed significant effects in favour of the DAs. Fewer women were undecided at first 
follow-up (RR 0.42, 96% CI: 0.24-0.74)22;30;31 or regretted their decision (RR 0.58, 
95%CI: 0.35-0.97)15;22 and a greater proportion of women felt they had enough 
information to make their decision when they were informed with a DA (RR 2.88, 95%CI: 
2.02-4.10)16;22;30. Most studies looking at satisfaction found a non-significant positive 
effect of DAs on satisfaction with decision16;24;26, decision-making process16, and 
experience with birth and pregnancy17. Kupperman et al. found a significant difference in 
satisfaction with decision-making process at first follow-up (scale 0-10, DA 8.1 vs. 
control 7.5, (p<0.001).15   
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Only one study assessed accuracy of risk perception, by measuring the percentage of 
women with correct risk perception for intervention related to miscarriage and the risk of 
having a baby with Down syndrome. In this study, authors found a significantly larger 
percentage of women in the DA group had correct risk perception (p<0.001).15 
 
Choice behaviour and adherence to chosen option 
In the study by Kupperman et al. (prenatal testing), 48% of women in the DA group said 
that the intervention had affected their decision-making process, compared to 28% in the 
control group (OR 2.42, P<0.001).  Raynes-Greenow et al. (pain relief during labour) 
reported that women with the DA tended to consider their caregivers opinion more 
(37.8% vs. 30.7%, P= 0.09) and were more likely to make a shared decision with their 
care-provider (19.3% and 13.8%, P<0.05).  
Seven studies looked at patient preferences for the different treatment options at the 
time of first follow-up after the intervention. We pooled outcomes of the five studies that 
looked at prenatal testing decisions and found no significant difference between DA and 
control groups preference for testing (RR 1.04, 95% CI: 0.95, 1.14). However, 
presenting the information in a DA decreased the rate of women who were still undecided 
after receiving an intervention (RR 0.44, 95% CI: 0.26, 0.73)22;24;26;28. 
The pooled analyses of the studies on prenatal testing preferences did not show a 
difference in chosen option, but the actual uptake (actual number of women who 
underwent prenatal screening) was slightly higher among women informed with a DA (RR 
1.15, 95%CI 1.04, 1.24). In contrast, Nassar et al. reported an increase of women 
counselled with the DA who intended to undergo external cephalic version (77.1 vs. 
55.47%, RR 1.38 (95%CI 1.12, 1.70), however there was no significant difference in 
number of women who actually underwent the procedure.  
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Health and Heath care system outcomes 
Three out of nine studies reported on neonatal outcomes16;22(add Nassar reference) ( 
Apgar score  at 1 and 5 minutes post partum, birth weight, preterm delivery and cephalic 
presentation) and  found no significant difference between DA and control groups.    
There was also no difference in maternal mortality and morbidity, maternal length of stay 
in hospital self-esteem or depression scores between groups. Assessment of the impact 
of DAs on health care costs revealed no difference in resource-use by mothers and babies 
in the intervention  versus the control group.19,32 Although, Bekker et al. reported the 
consultation length was slightly longer by six minutes in the DA group (MD 5.9, 95% CI: 
1.15,10.65).                                                                                          
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DISCUSSION  
This is the first systematic review of DAs in obstetrics using a critical appraisal of study 
and DA qualities. We found that DAs in pregnancy care significantly decrease decisional 
conflict, increase knowledge, and decrease anxiety. Furthermore, DAs reduce decisional 
regret, reduce the amount of women who are undecided and increase accuracy of risk 
perception. Subgroup analyses highlight that the type of decision support technique has 
an impact on outcomes with counselling resulting in less decisional conflict and anxiety, 
but knowledge is not as enhanced. Results also reveal that the control group did make a 
difference to results with usual care compared with an information leaflet, as the control 
group was more inferior, and led to the DA having a stronger effect on outcomes.  
 
These findings suggest that DAs improve patient decision making compared to usual 
care. Furthermore, the greatest benefits were found when the decision support technique 
was implemented in the form of counselling from a care provider; involving information, 
discussion of options and clarification of values, resulting in the greatest benefits to 
patients in the form of less uncertainty and anxiety.19 Written information did also result 
in greater recall of information. Thus, although the absolute differences between 
treatment groups were relatively small for some outcomes and some may question the 
clinical relevance, these findings suggest that there may be some patients that may 
benefit from increased information and support in their decision making.  
 
Findings were also consistent regardless of the quality of the DA, although there was no 
explicit ranking or guideline for the interpretation of IPDAS quality scores and our own 
arbitrary cut-points of less and greater than 60 may not have been sensitive enough. 
However, the IPDAS criteria for DAs form an evidence based tool to develop and assess 
information leaflets and DAs.   
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In our opinion, it is important to separate these DAs from other topics as decisions in 
obstetrics do not only concern the patient / mother, but also the fetus which may 
influence decisional conflict and anxiety. Furthermore, this is the first review which has 
assessed the quality of pregnancy-related DAs to provide an overview of their 
effectiveness and utility. One of the strengths of this review is the generalisability of the 
findings with the additional value of DAs proven in a wide range of pregnant populations 
and covering the prenatal period from first trimester until birth. 
 
Of included studies, only half assessed if patients felt that they had ‘made the right 
choice for them’, a decision consistent with their values. Although, the studies assessing 
these outcomes showed significant effects in favour of the DAs, measures used varied 
widely. Three studies used the outcome ‘undecided’, two studies ‘decision regret’ and two 
studies ‘satisfaction with decision’. Generally, a reduction in validated outcome measures 
such as DCS, knowledge and anxiety make it plausible that patients are helped by DAs in 
making the best choice according to their own values, but there is need for an overall, 
uniform outcome measure to base this assumption.     
 
Our study does have some limitations. One of the main issues with the review is the 
heterogeneity among the trials. This may be explained by the variety in topics of the 
DAs, the different control groups among the studies, the difference in outcome 
measurement scales, and cultural differences within the countries concerning health care 
and patient involvement in decision making. We tried to overcome these potential 
sources of heterogeneity by conducting random effect and subgroup analyses. These 
analyses revealed that, while some of the differences in outcomes could be explained by 
the type of control group, the study quality did not have any effect on results. Other 
weaknesses of the review were the observed asymmetry in the funnel plot for the DCS, 
indicating possible publication bias (figure of the funnel plot is available online) and that 
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evidence in the included studies was graded as being of moderate quality on the GRADE 
scale. A further limitation of the review is the percentage of loss to follow up which was 
over 10% in some of the included studies. However, impact on meta-analyses results 
were minimised as the proportion of loss-to follow-up in each study was similar in the 
intervention versus the comparison group.   
 
Surprisingly, of all developed DAs, only three were available on the internet and a further 
two were obtained on request. This may be due to a lack of resources for implementation 
or support for the intervention. A number of trials included in the review were funded by 
grants and it may be that these had funding for development and evaluation, but no 
further resources to support implementation. This is confirmed by the fact that overall, 
we only found two studies assessing implementation of DAs in daily practice and both 
studies found that DAs were poorly used in daily practice and experienced many barriers 
especially from physicians, despite positive attitudes to the use of DAs.33;34 This could be 
due to time pressure and ideas of non-productiveness of shared decision-making. Other 
possible barriers may involve the relevance of information presented to the particular 
setting, lack of availability or relevance of options presented in the DA and whether 
information is up-to-date. Identification of the barriers and facilitators that may be 
associated with the implementation of decision support techniques may increase their 
application and relevance. 
 
CONCLUSION 
Our systematic review highlights the positive effect of DAs on informed decision making 
in pregnancy care. Furthermore, the most positive benefits were when the decision 
support technique was implemented by a care provider. Future studies should focus on 
increasing the uptake of DAs in clinical practice by both describing the elements of 
‘effective DAs’ for their development, and provide advice on how pregnancy care 
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providers should utilise and implement DAs in their clinical practice. Identifying the 
barriers and facilitators to implementation is also important in increasing their relevance 
and application.  
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Figure 1: flow chart study selection process
Table 1: Study characteristics 
 Citation    Country N  DA N 
Contr
ol 
Desi
gn 
Decision intervention control Study population Timing of 
assessment  first 
follow-up 
Total 
IPDAS- 
score 
Pregnancy termination method        
Wong, 200629 UK 154 159 RCT Pregnancy termination 
method  
Information 
leaflet33 
Information 
leaflet on 
contraception 
<9 weeks gestation After intervention 38.0% 
(17/50) 
Prenatal testing        
Bekker, 200419 UK 50 56 RCT Prenatal diagnosis 
Down syndrome for 
women with a positive 
screening test. 
Structured 
counselling with 
decision analysis 
 
Normal 
counselling 
15 weeks gestation After intervention 45.5% 
(25/55)* 
Hunter, 200520 Canada 116 110 RCT Prenatal diagnosis for 
mothers of advanced 
maternal age  
Booklet, 
worksheet and 
audio-guide, 
option to discuss 
with a genetic 
counsellor 
Group 
counselling 
(usual care) 
<18 weeks gestation After intervention  63.6% 
(35/55)* 
Arimori, 200614 Japan 38 43 RCT Prenatal testing  Counselling by 
nurse based on 
the Ottawa 
decision support 
framework  
 
Usual 
counselling 
11-15 weeks gestation After intervention  7.3% 
(15/55)* 
Nagle, 200821 Australia 167 172 Cluste
r RCT 
Prenatal testing in 
primary care  
Booklet with 
worksheet34 
Standard 
information 
pamphlet 
<12 weeks gestation, 
consultation by GP’s 
After making 
decision or at 14 
weeks gestation 
74.1% 
(43/58) 
Kupperman, 
200915 
USA 244 252 RCT Prenatal testing for 
Down syndrome  
Interactive 
computer 
program  
Computerised 
educational 
booklet 
<20 weeks gestation  1-2 weeks after 
intervention^ 
 
58.2% 
(32/55)*  
Breech presentation         
Nassar, 200722 Australia 102 98 RCT Singleton Breech 
presentation  
Booklet, worksheet 
and audio-CD35 
Usual care >34 weeks gestation 1 week after 
intervention  
75.5% 
(40/53) 
Vaginal birth after CS         
Shorten, 200517 Australia 99 92 RCT Mode of delivery after 
previous caesarean 
section 
Booklet with 
value clarification 
exercise 36 
Usual care Inclusion 12-18 weeks 
gestation, information 
at 28 weeks gestation 
8 weeks after 
intervention  
68.0% 
(34/50)* 
Montgomery, 
200724 
UK 196 202 RCT Mode of delivery after 
previous caesarean 
section 
Computerized  
information and 
decision analysis 
program37  
Usual care 19-35 weeks gestation 37 weeks gestation 58 % 
(29/50) 
Pain relief in labour         
Raynes-
Greenow, 
201016 
Australia  395 201 RCT Pain relief in labour  a. Booklet and 
worksheet  
b. Booklet, 
worksheet and 
audio-guide38 
Information 
leaflet 
>36 weeks gestation, 
primiparous planning 
on vaginal delivery 
1 week after 
intervention 
83.0% 
(44/53) 
^regret and satisfaction assessed at 26-30 weeks of gestation.  
*IPDAS-score based on information in article, full decision aid not available for scoring  
 
 
Table 2: Methodological quality summary: risk of biases for each included study 
 
Randomisation Allocation 
concealment 
Patient 
blinding 
Assessor 
blinding 
Incomplete 
data 
Intention 
to treat 
analysis 
Raynes-
Greenow 2010 
⊕ ⊕ ⊕ ∅ ∅ ⊕ 
Kupperman 
2009 
⊕ ⊕ ⊕ ∅ ⊕ ⊗ 
Nagle, 2007 ⊕ ⊕ ⊗ ⊗ ∅ ⊕ 
Nassar 2007 ⊕ ⊕ ∅ ∅ ⊕ ⊕ 
Montgomery, 
2007 
⊕ ⊕ ⊗ ⊕ ⊕ ⊕ 
Wong, 2006 ⊕ ⊕ ⊕ ⊗ ⊕ ⊕ 
Arimori, 2006 ⊕ ⊕ ⊗ ⊗ ∅ ⊗ 
Shorten, 2005 ⊕ ⊕ ∅ ⊗ ∅ ⊗ 
Hunter, 2005 ⊕ ⊕ ⊗ ∅ ⊗ ⊕ 
Bekker 2004 ⊕ ⊕ ⊗ ∅ ⊕ ⊗ 
⊕ Good, ∅ Moderate, ⊗ Missing information and/or data 
 
 
 
 
Overall Decisional conflict (0-100 score)
St d DA M (SD) C M (SD)
Mean Difference
Random IV (95% CI)
Figure 2: Forest plot decisional conflict
u y                  n   ean     n   ean , ,  
Raynes-
Greenow 349     23.9 (10.6)    178    24.9 (12.9) -1.00 (-3.20, 1.20)
Nassar 98       4.6 (9.0)        90      13.5 (19.2)
-8.90 (-13.25,-4.55)
Montgomery        198     23.6 (15.1)    201    27.8 (14.6) -4.20 (-7.12,-1.28)
Nagle                   167     17.75 (12.3)  171    16.25 (13.75)
1.50 (-1.27, 4.27)
Arimor 38      25.0 (13.0)     43      30.8 (12.5)
-5.75 (-11.32,-0.18)
Shorten                99      23.5 (12.5)     88      29.5 (18.3)
6 00 ( 10 54 1 46)
F D i i Aid MD F C t l
-15 -10 -5 0 5
- .  - . ,- .
Overall                      949                           771
Heterogeneity: Chi squared= 22.99 df= 5 p= <0.001 I squared= 78.3%
Test for overall effect: Z= 2.40 p= 0.016
-3.66 (-6.65,-0.68)
avours ec s on           avours on ro
Fi  3  F t l t k l d
Knowledge (0-100 score)
Mean difference
gure : ores p o now e ge
Study               DA n     Mean (SD)    C n     Mean (SD)
 
Random, IV (95% CI)
Raynes-
Greenow 349     65.1 (29.5)    178      56.6 (27.4) 8.60 (3.52, 13.68)
Nassar 98       88.0  (19.0)    90       79.0 (18.0) 9.00 (3.71, 14.29)
Wong               154     85.0 (31.7)    159      60.0 (21.5) 25.00 (18.98, 31.02)
Montgomery    196     68.0 (18.5)     202     57.5 (18.5) 10.50 (6.86, 14.14)
Bekker 50       74.0 (14.5)     56       71.5 (17.2) 2.50 (-3.54, 8.54)
Overall                   847                          685
Heterogeneity: Chi squared = 29.83 df= 4 p= <0.001 I squared= 86.6%
11.06 (4.85, 17.27)
Favours Control     MD     Favours Decision Aid
-10 0 10 20 30 40
Test for overall effect: Z= 3.49 p= <0.001
Anxiety (20-80 score) Mean difference
Figure 4: Forest plot Anxiety 
Study                 DA n   Mean (SD)   C n   Mean (SD) Random, IV (95% CI)
Raynes-
Greenow 349    33.3 (9.3)       178    34.4 (11.0) -1.10 (-2.99, 0.79)
Nassar 98 41.4 (12.5) 90 44.4 (13.9) -3 00 (-6 79 0 79)                   .  . , .
Montgomery 196    38.7 (12.2)     195    42.1 (12.2) -3.40 (-5.82,-0.98)
Nagle     134    37.2 (12.1)     137    37.4 (12.6) -0.16 (-3.10, 2.78)
Wong 154 54 0 (12 7) 159 54 0 (19 3) 0 00 ( 3 61 3 61)    .  .          .  . .  - . , .
Bekker 50      58.9 (16.7)      56     61.2(13.74) -2.30 (-8.22, 3.62)
Overall 1097 925 
Heterogeneity: Chi squared= 4 65 df=56 (p= 0 46) I squared= 0 0%
-1.59 (-2.75,-0.43)
Favours Decision aid         MD        Favours Control
-15 -10 -5 0 5
   .    .    .
Test for overall effect: Z=2.69 p= 0.007
l l d l flFigure 5 Funne  p ot ecisiona  con ict
Table 3: Results of subgroup analysis 
Outcome Subgroup analysis Subgroup WMD (95% CI) I2 
DCS  Type of control 
intervention 
Usual care14;22;24;28 -5.75 (-7.75, -3.75) 4.3% 
Information programme 16;21 0.0 (-2.5, 2.5) NA 
Type of intervention Booklet 16;21;22;28 -3.75 (-7.25, -2.5) 81% 
Interactive computer 
programme 24 
-4.2, SE: 1.5 - 
Counselling 14  -5.75 SE: 2.75 - 
IPDAS score >60 14;16;21;22;28 -3.75 (-7.25, -0.25) 81% 
<60 24 -4.5 (-7.25, -2) NA 
Knowledge  Type of control 
intervention 
Usual care19;22;24;29 11.7 (3.74, 19.65) 90% 
Information programme 16 8.6 SE:2.59 - 
Type of intervention Booklet 16;22;29 9.6 (-1.42, 20.67) 94% 
Interactive computer 
programme 24 
 
10.5 SE: 1.85 - 
Counselling 19 2.5 SE:3.08 - 
IPDAS score >60 16;22 4.59 (-3.67, 12.85) 87 
<60 19;24;29 
 
12.62 (1.45, 23.8) 93 
Anxiety  Type of control 
intervention 
Usual care19;22;24;29 -2.47 (-4.17, -0.77) 0% 
Information programme 16;21 -0.83 (-2.42, 0.76) NA 
Type of intervention Booklet 16;21;22;29 -1.21 (-2.42, -0.01) 0% 
Interactive computer 
programme 24 
 
-3.4 SE: 1.24 - 
Counselling 19 -5.75 SE: 2.75 - 
IPDAS score >60 16;21;22  -1.37 (-2.65, -0.09) 0% 
<60 19;24;29 -2.24 (-4.39, -0.05) 15% 
 
 
